Agent for prophylaxis and treatment of liver disease
CA 2369560 C · Owner: Mitsubishi Pharma Corporation · Inventors: Uehata, Masayoshi; Nawata, Hajime; Nakamuta, Makoto
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Preventives/remedies for liver diseases which contain compounds having an Rho kinase inhibitory activity; and liver astrocyte activation inhibitors. Because of having excellent effects of inhibiting the activation of liver astrocytes preventing the fibrosis of liver tissues etc. compounds having an Rho kinase , inhibitory activity (for example (+)- trans-4-(1-aminoethyl)-1-(4-, pyridylcarbamoyl) cyclohexane) are useful in preventing and treating various liver diseases such as hepatitis, hepatic fibrosis liver cirrhosis and liver , cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 27, 2000 and granted February 1, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 27, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 27, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.